• English
    • français
  • English 
    • English
    • français
  • Login
Search 
  •   Repository Home
  • Research Papers (RP)
  • RP-School of Pure and Applied Sciences
  • RP-Department of Zoological Sciences
  • Search
  •   Repository Home
  • Research Papers (RP)
  • RP-School of Pure and Applied Sciences
  • RP-Department of Zoological Sciences
  • Search
JavaScript is disabled for your browser. Some features of this site may not work without it.

Search

Show Advanced FiltersHide Advanced Filters

Filters

Use filters to refine the search results.

Now showing items 1-9 of 9

  • Sort Options:
  • Relevance
  • Title Asc
  • Title Desc
  • Issue Date Asc
  • Issue Date Desc
  • Results Per Page:
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
Thumbnail

Efficacy of Trypan: a Diminazene Based Drug as Antileishmanial Agent 

Gicheru, M. M.; Macharia, J. C.; Bourdichon, A. J. (PubMed, 2004)
Trypan, a diamidine based drug, was tested as an antileishmanial agent. Duplicate cultures of both Leishmania major and Leishmania donovani promastigotes in M199 medium and Trypan at various concentrations were tested. The ...
Thumbnail

Prevalence of Antibodies and Cell Mediated Immune Response against Leishmania Major in Feral Nonhuman Primates from Kenya. 

Gicheru, M. M.; Jeneby, M. M.; Macharia, J. C.; Carlsson, H. E.; Suleman, M. A. (PubMed, 2009)
In Kenya, Leishmania major is responsible for human cutaneous leishmaniasis (CL). Natural infection with L. major of a vervet monkey and experimental susceptibility of some nonhuman primates (NHPs) from Kenya has been ...
Thumbnail

Leishmania parasite specific CD4 + synergizes and correlates positively with CD8 + T cells in the production of gamma interferon foll owing immunization of the vervet monkey (Chlorocebus aethiops) model 

Gicheru, M. M.; Mutiso, J. M.; Macharia, J. C.; Mucheru, P. M.; Onkoba, W. N.; Maloba, F. C. (2013-03)
Although there is currently no vaccine against leishmaniasis in routine use anywhere in the world, cases of self cure in cutaneous leishmaniasis, accompanied by solid immunity to reinfection, make vaccine development a ...
Thumbnail

A Review of Adjuvants for Leishmania Vaccine Candidates. 

Gicheru, M. M.; Mutiso, J. M.; Macharia, J. C. (PubMed, 2010)
Over the last decade, there has been a flurry of research on adjuvants for vaccines, and several novel adjuvants are now licensed products or in late stage clinical development. The success of adjuvants in enhancing the ...
Thumbnail

Immunization with Leishmania Vaccine-Alum-Bf'G and Montanide ISA 720 Adjuvants Induces Low-Grade Type 2 Cytokines and High Levels of IgG2 Subclass Antibodies in the Vervet Monkey (Chlorocebus aethiops) Model 

Gicheru, M. M.; Mutiso, J. M.; Macharia, J. C. (Blackwell Publishing Ltd., 2012-07-29)
The availability of hundreds of adjuvants has prompted a need for identifying rational standards for the selection of adjuvant formulation based on sound immunological principles for human vaccines. As cytokines elaborated ...
Thumbnail

In Vitro and in Vivo Antileishmanial Efficacy of a Combination Therapy of Diminazene and Artesunate against Leishmania Donovani in BALB/c Mice. 

Gicheru, M. M.; Mutiso, J. M.; Macharia, J. C.; Barasa, M.; Taracha, E.; Bourdichon, A. J. (PubMed, 2011)
The in vitro and in vivo activity of diminazene (Dim), artesunate (Art) and combination of Dim and Art (Dim-Art) against Leishmania donovani was compared to reference drug; amphotericin B. IC50 of Dim-Art was found to be ...
Thumbnail

Safety and Skin Delayed-type Hypersensitivity Response in Vervet Monkeys Immunized with Leishmania Donovani Sonicate Antigen Delivered with Adjuvants 

Mutiso, J. M.; Macharia, J. C.; Taracha, E.; Wafula, K.; Rikoi, H.; Gicheru, M. M. (Institute of Primate Research, 2013-01)
In this study, we report on the safety and skin delayed-type hypersensitivity (DTH), responses of the Leishmania donovani whole cell sonicate antigen delivered in conjunction with alum-BCG (AlBCG), Montanide ISA 720 (MISA) ...
Thumbnail

Immunology of leishmaniasis 

Gicheru, M. M.; Mutiso, J. M.; Macharia, J. C.; Ozwara, H. (2013-06)
Resolution of leishmanial infection is dependent on the coordinated interactions between components of cell mediated immune response, central to which is the activation of targeted T-cell populations for appropriate cytokine ...
Thumbnail

Montanide ISA 720 is more effectiv e than BCG as an adjuvant for Leishmania killed vacci ne in BALB/c mice 

Gicheru, M. M.; Mutiso, J. M.; Macharia, J. C.; Kariuki, T. M. (2009)

Designed by Library ICT Team copyright © 2017 
Contact Us | Send Feedback

 

 

Browse

All of RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

LoginRegister

Discover

AuthorGicheru, M. M. (9)
Macharia, J. C. (9)
Mutiso, J. M. (7)Bourdichon, A. J. (2)Taracha, E. (2)Barasa, M. (1)Carlsson, H. E. (1)Jeneby, M. M. (1)Kariuki, T. M. (1)Maloba, F. C. (1)... View MoreSubjectAdjuvants (2)Leishmaniasis (2)adjuvants (1)alum (1)BALB/c (1)BCG (1)CD4 + Th1 and CD8 + T cells (1)cutaneous leishmaniasis (1)Delayed-type hypersensitivity (DTH) (1)Human (1)... View MoreDate Issued2013 (3)2012 (1)2011 (1)2010 (1)2009 (2)2004 (1)

Designed by Library ICT Team copyright © 2017 
Contact Us | Send Feedback